
Absci Corp
ABSINASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$5.97
Day High
$7.34
Day Low
$5.85
Prev. Close
$6.08
VolumeShares traded today.
9.37M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$1.05B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-8.14
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$7.34
52W LowLowest price over the past 52 weeks.
$2.24
50D MAAverage closing price over the last 50 trading days.
$4.22
200D MAAverage closing price over the last 200 trading days.
$3.42
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+32.6%1M
+43.3%6M
+119.9%YTD
+87.0%1Y
+154.7%About
ABS-201 is an AI-designed monoclonal antibody against the prolactin receptor (PRLR) currently in Phase 1/2a clinical trial for the treatment of androgenic alopecia and endometriosis. It is taken by subcutaneous injection. ABS-201 is a possible first-in-class drug with a novel mechanism of action in the potential treatment of hair loss. ABS-201 is under development by Absci.
www.absci.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade ABSI
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.